메뉴 건너뛰기




Volumn 75, Issue 2, 2016, Pages 474-478

Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; COLLAGEN; HYDROXYPROLINE; UROKINASE RECEPTOR; PLAUR PROTEIN, MOUSE;

EID: 84954367716     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207803     Document Type: Article
Times cited : (21)

References (19)
  • 1
    • 33847348491 scopus 로고    scopus 로고
    • Systemic sclerosis: A prototypic multisystem fibrotic disorder
    • Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
    • (2007) J Clin Invest , vol.117 , pp. 557-567
    • Varga, J.1    Abraham, D.2
  • 2
    • 84925986810 scopus 로고    scopus 로고
    • Cardiac manifestations in systemic sclerosis
    • Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol 2014;6:993-1005.
    • (2014) World J Cardiol , vol.6 , pp. 993-1005
    • Lambova, S.1
  • 3
    • 0036124419 scopus 로고    scopus 로고
    • Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients
    • Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-53.
    • (2002) Medicine (Baltimore) , vol.81 , pp. 139-153
    • Ferri, C.1    Valentini, G.2    Cozzi, F.3
  • 4
    • 0033767899 scopus 로고    scopus 로고
    • Severe organ involvement in systemic sclerosis with diffuse scleroderma
    • Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
    • (2000) Arthritis Rheum , vol.43 , pp. 2437-2444
    • Steen, V.D.1    Medsger, T.A.2
  • 5
    • 77249130200 scopus 로고    scopus 로고
    • Heart involvement in systemic sclerosis: Evolving concept and diagnostic methodologies
    • Meune C, Vignaux O, Kahan A, et al. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010;103:46-52.
    • (2010) Arch Cardiovasc Dis , vol.103 , pp. 46-52
    • Meune, C.1    Vignaux, O.2    Kahan, A.3
  • 6
    • 78650529151 scopus 로고    scopus 로고
    • Primary myocardial involvement in systemic sclerosis: Evidence for a microvascular origin
    • Allanore Y, Meune C. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin Exp Rheumatol 2010;28(5 Suppl 62):S48-53.
    • (2010) Clin Exp Rheumatol , vol.28 , Issue.5 , pp. S48-53
    • Allanore, Y.1    Meune, C.2
  • 7
    • 0025303192 scopus 로고
    • A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)
    • Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-62.
    • (1990) J Rheumatol , vol.17 , pp. 656-662
    • Follansbee, W.P.1    Miller, T.R.2    Curtiss, E.I.3
  • 8
    • 36048986654 scopus 로고    scopus 로고
    • Pattern and distribution of myocardial fibrosis in systemic sclerosis: A delayed enhanced magnetic resonance imaging study
    • Tzelepis GE, Kelekis NL, Plastiras SC, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36.
    • (2007) Arthritis Rheum , vol.56 , pp. 3827-3836
    • Tzelepis, G.E.1    Kelekis, N.L.2    Plastiras, S.C.3
  • 9
    • 84894900398 scopus 로고    scopus 로고
    • Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression
    • Pieroni M, De Santis M, Zizzo G, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 2014;43:526-35.
    • (2014) Semin Arthritis Rheum , vol.43 , pp. 526-535
    • Pieroni, M.1    De Santis, M.2    Zizzo, G.3
  • 11
    • 84905158456 scopus 로고    scopus 로고
    • Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: A new model of experimental scleroderma?
    • Manetti M, Rosa I, Milia AF, et al. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Ann Rheum Dis 2014;73:1700-9.
    • (2014) Ann Rheum Dis , vol.73 , pp. 1700-1709
    • Manetti, M.1    Rosa, I.2    Milia, A.F.3
  • 12
    • 57349182712 scopus 로고    scopus 로고
    • The absence of uPAR is associated with the progression of dermal fibrosis
    • Kanno Y, Kaneiwa A, Minamida M, et al. The absence of uPAR is associated with the progression of dermal fibrosis. J Invest Dermatol 2008;128:2792-7.
    • (2008) J Invest Dermatol , vol.128 , pp. 2792-2797
    • Kanno, Y.1    Kaneiwa, A.2    Minamida, M.3
  • 13
    • 84930674420 scopus 로고    scopus 로고
    • Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy
    • Mueller KA, Mueller II, Eppler D, et al. Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS One 2015;10:e0126707.
    • (2015) PLoS One , vol.10 , pp. e0126707
    • Mueller, K.A.1    Mueller, I.I.2    Eppler, D.3
  • 14
    • 33744962186 scopus 로고    scopus 로고
    • Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator
    • Stempien-Otero A, Plawman A, Meznarich J, et al. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator. J Biol Chem 2006;281:15345-51.
    • (2006) J Biol Chem , vol.281 , pp. 15345-15351
    • Stempien-Otero, A.1    Plawman, A.2    Meznarich, J.3
  • 15
    • 34347384693 scopus 로고    scopus 로고
    • Urokinase receptor cleavage: A crucial step in fibroblast-to-myofibroblast differentiation
    • Bernstein AM, Twining SS, Warejcka DJ, et al. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell 2007;18:2716-27.
    • (2007) Mol Biol Cell , vol.18 , pp. 2716-2727
    • Bernstein, A.M.1    Twining, S.S.2    Warejcka, D.J.3
  • 16
    • 84863358460 scopus 로고    scopus 로고
    • Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: Effect on β1 integrin activity and α-SMA stress fiber assembly
    • Wang L, Pedroja BS, Meyers EE, et al. Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly. PLoS One 2012;7:e33915.
    • (2012) PLoS One , vol.7 , pp. e33915
    • Wang, L.1    Pedroja, B.S.2    Meyers, E.E.3
  • 17
    • 60849136639 scopus 로고    scopus 로고
    • Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
    • Prager GW, Mihaly J, Brunner PM, et al. Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Blood 2009;113:1383-90.
    • (2009) Blood , vol.113 , pp. 1383-1390
    • Prager, G.W.1    Mihaly, J.2    Brunner, P.M.3
  • 18
    • 77955142127 scopus 로고    scopus 로고
    • Mechanisms in the loss of capillaries in systemic sclerosis: Angiogenesis versus vasculogenesis
    • Manetti M, Guiducci S, Ibba-Manneschi L, et al. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 2010;14:1241-54.
    • (2010) J Cell Mol Med , vol.14 , pp. 1241-1254
    • Manetti, M.1    Guiducci, S.2    Ibba-Manneschi, L.3
  • 19
    • 33845666597 scopus 로고    scopus 로고
    • Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: Failure of association in systemic sclerosis endothelial cells
    • Margheri F, Manetti M, Serratì S, et al. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells. Arthritis Rheum 2006;54:3926-38.
    • (2006) Arthritis Rheum , vol.54 , pp. 3926-3938
    • Margheri, F.1    Manetti, M.2    Serratì, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.